| GTO ID | GTC1901 |
| Trial ID | NCT03545815 |
| Disease | Solid Tumor |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Study of CRISPR-Cas9 Mediated PD-1 and TCR Gene-knocked Out Mesothelin-directed CAR-T Cells in Patients With Mesothelin Positive Multiple Solid Tumors. |
| Year | 2018 |
| Country | China |
| Company sponsor | Chinese PLA General Hospital |
| Other ID(s) | CHN-PLAGH-BT-028 |
| Cohort 1 | |||||||
|
|||||||